Accuray Incorporated (ARAY) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Accuray Incorporated  (NASDAQ: ARAY)

Select the Financial Report: Select the Period:


Description of Accuray Incorporated's Business Segments


Accuray Incorporated is a well-established provider of advanced radiation therapy solutions, dedicated to improving patient outcomes and enhancing the efficacy of cancer treatment. The companys comprehensive offerings include a variety of products and services that cater to the needs of healthcare professionals and patients alike.

Segments
Accuray operates through two primary segments:

1. Radixact Segment: This segment features advanced treatment systems that provide precision and personalization in radiation therapy.
- Radixact System: The Radixact System is designed to empower clinicians with a powerful, flexible solution for delivering precise radiation therapy. It integrates advanced software and hardware components, facilitating real-time imaging and treatment delivery, which is essential for effectively treating moving tumors often found in tissues like the lungs and abdomen.

- TomoTherapy System: This system is pivotal in cancer care due to its ability to combine Intensity-Modulated Radiation Therapy (IMRT) with integrated CT imaging. The TomoTherapy System allows for highly conformal radiation delivery, optimizing dose distribution while sparing surrounding healthy tissue. The combination of imaging and therapy helps clinicians adapt treatment plans based on real-time data, enhancing the quality of care.

2. CyberKnife Segment: This segment includes the renowned CyberKnife System, which is notable for its unique approach to radiation therapy.
- CyberKnife System: Distinctively non-invasive, the CyberKnife System utilizes advanced imaging and motion-tracking technologies, enabling the delivery of highly precise radiation to tumors. Its robotic arm allows for intricate movement and treatment from various angles, accommodating patient positioning and tumor motion. This adaptability minimizes damage to surrounding healthy tissues and makes it suitable for various types of cancer.

Products
Accurays product lineup is characterized by cutting-edge technology that focuses on precision and patient-centric treatment:

1. Radixact System: A sophisticated radiation therapy system that leverages continuous imaging for optimal treatment delivery. Some of its features include adaptive treatment capabilities, intricate motion management, and improved patient comfort.

2. TomoTherapy System: Known for its versatility and efficiency, it combines precise treatment planning with CT imaging, ensuring that radiation is delivered accurately to the tumor while preserving healthy structures.

3. CyberKnife System: The system is highly regarded for its accuracy and flexibility. It is suitable for a broad range of tumors and characteristics of patient-specific treatment, including tracking tumor movement throughout the treatment process.

Services
Accuray complements its product offerings with a suite of services aimed at supporting healthcare providers:

1. Clinical Services: This includes comprehensive consultation services, tailored training programs for clinicians, and ongoing technical support to ensure optimal use of the radiation therapy systems. Accuray provides expertise in treatment planning and implementation to facilitate the best possible patient outcomes.

2. Maintenance Services: Accuray offers maintenance contracts that incorporate regular inspections, remote assistance, and on-site repairs. These services are essential for maintaining the reliability and performance of the Radixact and CyberKnife systems. Regular software updates and system upgrades are provided to enhance functionality and ensure consistency with the latest technological advancements.

3. Education and Research: Committed to fostering ongoing education in the field of radiation oncology, Accuray provides numerous educational resources, workshops, and continuing medical education (CME) opportunities. Collaborations with research institutions further contribute to the advancement of radiation therapy techniques and treatments, ensuring that clinicians have access to the latest findings and innovations in cancer care.

Conclusion
In summary, Accuray Incorporated stands at the forefront of radiation therapy technology, offering a diverse range of innovative products and comprehensive services aimed at enhancing patient care. Through its commitment to precision in treatment delivery, clinician education, and ongoing support, Accuray is dedicated to advancing the landscape of cancer treatment and improving the lives of patients around the world.


Composition of Accuray Incorporated Revenues by Segments

 
Product    171.14 % of total Revenue
Service    227.15 % of total Revenue
Americas    89.14 % of total Revenue
EIMEA    149.54 % of total Revenue
CN    67.52 % of total Revenue
JP    43.86 % of total Revenue
Asia Pacific    48.23 % of total Revenue

Q4 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Product 172.71 171.14 %
Service 229.24 227.15 %
Americas 89.96 89.14 %
EIMEA 150.91 149.54 %
CN 68.14 67.52 %
JP 44.26 43.86 %
Asia Pacific 48.68 48.23 %
Total 100.92 100 %




Q4 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Product - -
Service - -
Americas - 267.92 %
EIMEA - 271.99 %
CN - -
JP - -
Asia Pacific - 422.24 %
Total -77.96 % -3.24 %




Q4 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -1.94 -




Q4 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Accuray Incorporated Divisions, Sales by Country

 
Americas   Americas Segment contribution to total sales 19.38 % of total Revenue
Asia Pacific   Asia Pacific Segment contribution to total sales 10.34 % of total Revenue
Long-term Warranty and Service   Long-term Warranty and Service Segment contribution to total sales 14 % of total Revenue
Europe India Middle East and Africa   Europe India Middle East and Africa Segment contribution to total sales 31.5 % of total Revenue
China   China Segment contribution to total sales 0 % of total Revenue
Japan   Japan Segment contribution to total sales 0 % of total Revenue
United States   United States Segment contribution to total sales 0 % of total Revenue
Rest of world   Rest of world Segment contribution to total sales 0 % of total Revenue


Twelve months ended 2025
ARAY s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Americas 88.77 19.38 %
Asia Pacific 47.38 10.34 %
Total 457.97 100 %
Long-term Warranty and Service 64.10 14 %
Europe India Middle East and Africa 144.26 31.5 %
China 0.00 0 %
Japan 0.00 0 %
United States 0.00 0 %
Rest of world 0.00 0 %


Twelve months ended 2025
ARAY s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -1.59 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Americas -1.54 % -
Asia Pacific 65.13 % -
Total 2.7 % -
Europe India Middle East and Africa -14.44 % -
China 17.39 % -
Japan 0 % -
United States -11.11 % -
Rest of world -4.26 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.